Support for Joints and Connective Tissue Elevated IGF-1 from MK-677 usage contributes to the regeneration of tendons, ligaments, and cartilage structures
Improved microcirculation nourishes hair roots
Copper can catalyze oxidation reactions, potentially accelerating the degradation of the peptide it is bound to and even neighboring molecules
- [Best Practices for Subcutaneous Peptide Injection]( *Journal of Clinical Pharmacy and Therapeutics*, 2022
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
Concern and Recommendations: Medically, the major concern right now with BPC 157 is a lack of evidence confirming safety in humans